Related Experiment Videos
Recent advances in Hodgkin's disease
1Department of Medicine, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
Current Opinion in Hematology
|July 1, 1996
Summary
Most Hodgkin's disease patients achieve cure with modern treatments. Research aims to improve efficacy and reduce long-term side effects, enhancing survival quality and length.
Area of Science:
- Oncology
- Hematology
- Molecular Biology
Background:
- Hodgkin's disease is largely curable with current therapies.
- Treatment focuses on maximizing efficacy while minimizing long-term adverse effects.
- Epidemiological and molecular studies enhance understanding of disease origins and development.
Purpose of the Study:
- To review current understanding and treatment of Hodgkin's disease.
- To highlight the ongoing challenges in fully elucidating disease pathogenesis.
- To emphasize the need for continued research into the heterogeneity and cellular basis of Hodgkin's disease.
Main Methods:
- Review of epidemiological data.
- Application of sophisticated molecular techniques.
- Analysis of current treatment strategies and outcomes.
Main Results:
- High cure rates are achievable for many Hodgkin's disease patients.
- Ongoing efforts focus on mitigating treatment-related long-term morbidities.
- Despite advances, a comprehensive pathogenetic model remains elusive.
Conclusions:
- Hodgkin's disease management balances cure rates with quality of life.
- Further research is needed to address the cellular heterogeneity and paucity of malignant cells.
- Understanding the etiology and pathogenesis is crucial for refining treatment paradigms.